Effect of MaxEPA in patients with SLE. A double-blind, crossover study
- PMID: 2186476
- DOI: 10.3109/03009749009102117
Effect of MaxEPA in patients with SLE. A double-blind, crossover study
Abstract
Seventeen patients with moderately active SLE participated in a double-blind, crossover study on the effect of MaxEPA, using olive oil as the control substance. During the first 3 months, 8/17 on Max EPA but only 2/17 on the control substance clinically and serologically improved (p = 0.05), but at 6 months there was no difference. The beneficial effect (if any) of MaxEPA on the disease was short-lived.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials